XSHE300107
Market cap640mUSD
Jan 10, Last price
8.37CNY
1D
-3.79%
1Q
-10.00%
Jan 2017
13.26%
IPO
15.32%
Name
Hebei Jianxin Chemical Co Ltd
Chart & Performance
Profile
Hebei Jianxin Chemical Co., Ltd. researches and develops, manufactures, and sells dyes intermediates in China. It offers metanilic acid, aniline-2, 5-disulfonic acid monosodium salt, 3- diethylaminophenol, m-aminophenol, sulfanilic acid, ODB-1, ODB-2, R-04, EBA, BBA, MMD, DPA, DBSP, BON, and n-butyl bromide. The company also provides 3,3'-dinitrodiphenyl sulfone; 3,3'-diamino diphenyl sulphone; 4,4'-dichloro diphenyl sulphone; 4,4'-diamino diphenyl sulfone; and m-trihydroxybenzene. Its products are used as intermediates for dyes, medicine, fiber, pesticide, dyestuffs, and synthesizing health care products; OBA for paper; color formers for thermal and carbonless paper; and developer and sensitizer for thermal paper. The company's products are also used as alkylating agent, solvent, and extracting agent for rare elements and organic synthesis; materials for curing agents, epoxy resins, engineering plastics, dyestuffs, polysulfone amides, and other polymers; monomer for polysulfonamide fiber; and pharmaceutical and auxiliary intermediates. It also exports its products to Europe, the United States, Japan, Korea, Taiwan, and Hong Kong. The company was founded in 2003 and is headquartered in Cangzhou, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | |||||||||
Revenues | 658,214 -11.35% | 742,465 18.20% | |||||||
Cost of revenue | 638,906 | 673,936 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | 19,308 | 68,530 | |||||||
NOPBT Margin | 2.93% | 9.23% | |||||||
Operating Taxes | (1,300) | 2,947 | |||||||
Tax Rate | 4.30% | ||||||||
NOPAT | 20,608 | 65,583 | |||||||
Net income | 14,733 -75.96% | 61,275 349.12% | |||||||
Dividends | (33,104) | (55,173) | |||||||
Dividend yield | 1.08% | 1.93% | |||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
Debt | |||||||||
Debt current | 10,735 | 137 | |||||||
Long-term debt | 535 | 137 | |||||||
Deferred revenue | 1,981 | 3,097 | |||||||
Other long-term liabilities | |||||||||
Net debt | (511,205) | (522,787) | |||||||
Cash flow | |||||||||
Cash from operating activities | 83,465 | 163,361 | |||||||
CAPEX | (85,492) | ||||||||
Cash from investing activities | (62,880) | ||||||||
Cash from financing activities | (1,871) | ||||||||
FCF | (2,192) | 43,669 | |||||||
Balance | |||||||||
Cash | 522,475 | 523,061 | |||||||
Long term investments | 4 | ||||||||
Excess cash | 489,564 | 485,937 | |||||||
Stockholders' equity | 1,072,173 | 1,237,407 | |||||||
Invested Capital | 990,147 | 976,824 | |||||||
ROIC | 2.10% | 6.77% | |||||||
ROCE | 1.29% | 4.61% | |||||||
EV | |||||||||
Common stock shares outstanding | 573,271 | 557,041 | |||||||
Price | 5.34 3.89% | 5.14 -16.69% | |||||||
Market cap | 3,061,267 6.92% | 2,863,190 -15.89% | |||||||
EV | 2,550,062 | 2,340,404 | |||||||
EBITDA | 83,895 | 134,313 | |||||||
EV/EBITDA | 30.40 | 17.42 | |||||||
Interest | 436 | 758 | |||||||
Interest/NOPBT | 2.26% | 1.11% |